One of the most challenging breast cancer subtypes is the triple-negative breast cancer (TNBC), which is characterized by the lack of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 (HER2) expression (2). This evidence concerns the gene ERBB2 and breast carcinoma.